Scholar Rock (SRRK)
(Real Time Quote from BATS)
$14.04 USD
+0.03 (0.21%)
Updated May 15, 2024 10:16 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
SRRK 14.04 +0.03(0.21%)
Will SRRK be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SRRK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SRRK
Wall Street Analysts See a 99.11% Upside in Scholar Rock Holding Corporation (SRRK): Can the Stock Really Move This High?
Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK)
SRRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Scholar Rock Holding Corporation (SRRK) Rating Upgrade to Strong Buy
Wall Street Analysts Think Scholar Rock Holding Corporation (SRRK) Could Surge 203.99%: Read This Before Placing a Bet
Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More
Other News for SRRK
Scholar Rock to Host Investor Day on May 22, 2024
Buy Rating Justified by Scholar Rock’s Promising Pipeline and Strategic Clinical Advancements
Analysts Are Bullish on Top Healthcare Stocks: Scholar Rock Holding (SRRK), Zimmer Biomet Holdings (ZBH)
SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q1 2024
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress